The office of the National Cancer Registry is closed due to government advice relating to Coronavirus.
Effective from the 16th March, employees are working remotely and can be contacted via email.
Please be advised that until the office reopens all FOI requests and SAR’s should be sent via email.
We are not in the position to respond to FOI requests and SAR’s received via post.
The office will remain closed until further notice.
| Cancer | Years | Method | Sex | Age | Survived | Net survival | 95% lower | 95% upper |
|---|---|---|---|---|---|---|---|---|
| All ex C44 | 2010-2014 | hybrid | Both | 15-99 | 1.00 years | 77.4% | 77.1% | 77.7% |
| All ex C44 | 2010-2014 | hybrid | Both | 15-99 | 5.00 years | 62.4% | 62.0% | 62.8% |
| All ex C44 | 2010-2014 | hybrid | Both | 15-99 | 10.00 years | 58.5% | 57.9% | 59.2% |
| All ex C44 | 2010-2014 | hybrid | Male | 15-99 | 1.00 years | 76.8% | 76.4% | 77.2% |
| All ex C44 | 2010-2014 | hybrid | Male | 15-99 | 5.00 years | 62.4% | 61.9% | 63.0% |
| All ex C44 | 2010-2014 | hybrid | Male | 15-99 | 10.00 years | 59.1% | 58.1% | 60.2% |
| All ex C44 | 2010-2014 | hybrid | Female | 15-99 | 1.00 years | 78.1% | 77.7% | 78.5% |
| All ex C44 | 2010-2014 | hybrid | Female | 15-99 | 5.00 years | 62.4% | 61.8% | 62.9% |
| All ex C44 | 2010-2014 | hybrid | Female | 15-99 | 10.00 years | 57.9% | 57.1% | 58.7% |
Printer-friendly version